A selective thyroid hormone β receptor agonist enhances human and rodent oligodendrocyte differentiation-Reference-Cited by-同舟云学术

A selective thyroid hormone β receptor agonist enhances human and rodent oligodendrocyte differentiation

Published:2014-05-24 Issue:9 Volume:62 Page:1513-1529
ISSN:0894-1491
Container-title:Glia
language:en
Short-container-title:Glia

Author:

Baxi Emily G.¹,Schott Jason T.¹,Fairchild Amanda N.¹,Kirby Leslie A.¹,Karani Rabia¹,Uapinyoying Prech¹,Pardo-Villamizar Carlos¹,Rothstein Jeffrey R.¹,Bergles Dwight E.²,Calabresi Peter A.¹

Affiliation:

1. Department of Neurology; Johns Hopkins University School of Medicine; Baltimore Maryland

2. Solomon H. Snyder Department of Neuroscience; Johns Hopkins University Medical School; Baltimore Maryland

Funder

National Institutes of Health

National Multiple Sclerosis Society

Maryland Stem Cell Foundation

The Silverman Foundation

Publisher

Wiley

Subject

Cellular and Molecular Neuroscience,Neurology

Reference60 articles.

1. Expression of alpha and beta thyroid receptors during oligodendrocyte differentiation;Baas;Neuroreport,1994a

2. Oligodendrocyte maturation and progenitor cell proliferation are independently regulated by thyroid hormone;Baas;Glia,1997

3. Expression of thyroid hormone receptor isoforms in rat oligodendrocyte cultures. Effect of 3,5,3'-triiodo-l-thyronine;Baas;Neurosci Lett,1994b

4. Posttranscriptional regulation of oligodendroglial thyroid hormone (T3) receptor beta 1 by T3;Baas;Int J Dev Neurosci,1998

5. A noninvasive genetic/pharmacologic strategy for visualizing cell morphology and clonal relationships in the mouse;Badea;J Neurosci,2003

Cited by 69 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Synaptic Plasticity and Cognitive Ability in Experimental Adult-Onset Hypothyroidism;Journal of Pharmacology and Experimental Therapeutics;2024-03-20

2. Incomplete remyelination via endogenous or therapeutically enhanced oligodendrogenesis is sufficient to recover visual cortical function;2024-02-22

3. Sobetirome rescues α‐synuclein‐mediated demyelination in an in vitro model of multiple system atrophy;European Journal of Neuroscience;2023-12-12

4. A Phase 1b, Open-Label Study to Evaluate the Safety and Tolerability of the Putative Remyelinating Agent, Liothyronine, in Individuals with MS;Neurotherapeutics;2023-09

5. Synthetic Thyroid Hormone Receptor-β Agonists Promote Oligodendrocyte Precursor Cell Differentiation in the Presence of Inflammatory Challenges;Pharmaceuticals;2023-08-25